US9676805B2 - Purifying organophosphorus compounds contaminated with chlorine - Google Patents
Purifying organophosphorus compounds contaminated with chlorine Download PDFInfo
- Publication number
- US9676805B2 US9676805B2 US15/109,745 US201515109745A US9676805B2 US 9676805 B2 US9676805 B2 US 9676805B2 US 201515109745 A US201515109745 A US 201515109745A US 9676805 B2 US9676805 B2 US 9676805B2
- Authority
- US
- United States
- Prior art keywords
- contaminated
- organophosphorus
- solution
- solvent
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- TZERJDWGIGECAN-UHFFFAOYSA-N COC1=CC(C2=CC(C)=CC(C(C)(C)C)=C2OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)=C(OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)C(C(C)(C)C)=C1 Chemical compound COC1=CC(C2=CC(C)=CC(C(C)(C)C)=C2OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)=C(OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)C(C(C)(C)C)=C1 TZERJDWGIGECAN-UHFFFAOYSA-N 0.000 description 2
- OYJHVTDGMQYIGR-UHFFFAOYSA-N CC1=CC(C)=C(O)C(C2=C(O)C(C)=CC(C)=C2)=C1.CC1=CC(C)=C(O)C=C1.CC1=CC(C)=C2OP(OC3=C(C4=CC(C)=CC(C)=C4OP4OC5=C(C=C(C)C=C5C(C)(C)C)C5=CC(C)=CC(C(C)(C)C)=C5O4)C=C(C)C=C3C)OC3=C(C=C(C)C=C3C)C2=C1.CC1=CC2=C(OP(Cl)O/C3=C(C)/C=C(C)\C=C\23)C(C)=C1.COC1=CC(C2=CC(C)=CC(C(C)(C)C)=C2O)=C(O)C(C(C)(C)C)=C1.ClP(Cl)Cl.I.[Fe] Chemical compound CC1=CC(C)=C(O)C(C2=C(O)C(C)=CC(C)=C2)=C1.CC1=CC(C)=C(O)C=C1.CC1=CC(C)=C2OP(OC3=C(C4=CC(C)=CC(C)=C4OP4OC5=C(C=C(C)C=C5C(C)(C)C)C5=CC(C)=CC(C(C)(C)C)=C5O4)C=C(C)C=C3C)OC3=C(C=C(C)C=C3C)C2=C1.CC1=CC2=C(OP(Cl)O/C3=C(C)/C=C(C)\C=C\23)C(C)=C1.COC1=CC(C2=CC(C)=CC(C(C)(C)C)=C2O)=C(O)C(C(C)(C)C)=C1.ClP(Cl)Cl.I.[Fe] OYJHVTDGMQYIGR-UHFFFAOYSA-N 0.000 description 1
- ZUXUZWFEPKFXFM-UHFFFAOYSA-O CC1=CC(C)=C(O)C(C2=C(O)C(C)=CC(C)=C2)=C1.CC1=CC(C)=C2OP(Cl)OC3=C(C=C(C)C=C3C)C2=C1.Cl[PH+](Cl)Cl Chemical compound CC1=CC(C)=C(O)C(C2=C(O)C(C)=CC(C)=C2)=C1.CC1=CC(C)=C2OP(Cl)OC3=C(C=C(C)C=C3C)C2=C1.Cl[PH+](Cl)Cl ZUXUZWFEPKFXFM-UHFFFAOYSA-O 0.000 description 1
- FIWMJULGLMACPG-UHFFFAOYSA-N CC1=CC(C)=C2OP3OC4=C(C=C(C)C=C4C4=C(O3)C(C(C)(C)C)=CC(C)=C4)CC3=C4OP(OC5=C(C=C(C)C=C5C)C2=C1)OC1=C(C=C(C)C=C1C)C4=CC(C)=C3 Chemical compound CC1=CC(C)=C2OP3OC4=C(C=C(C)C=C4C4=C(O3)C(C(C)(C)C)=CC(C)=C4)CC3=C4OP(OC5=C(C=C(C)C=C5C)C2=C1)OC1=C(C=C(C)C=C1C)C4=CC(C)=C3 FIWMJULGLMACPG-UHFFFAOYSA-N 0.000 description 1
- YLCDEHDFJACCEL-UHFFFAOYSA-N CC1=CC(C2=C(O)C(C)=CC(C)=C2)=C(O)C(C)=C1.CC1=CC=C(O)C(C)=C1 Chemical compound CC1=CC(C2=C(O)C(C)=CC(C)=C2)=C(O)C(C)=C1.CC1=CC=C(O)C(C)=C1 YLCDEHDFJACCEL-UHFFFAOYSA-N 0.000 description 1
- UGOJBNLWHOIITI-UHFFFAOYSA-N CC1=CC2=C(OP(OC3=C(C4=C(OP5OC6=C(C=C(C)C=C6C(C)(C)C)C6=C(O5)C(C(C)(C)C)=CC(C)=C6)C(C)=CC(C)=C4)C=C(C)C=C3C)OC3=C2C=C(C)C=C3C)C(C)=C1.COC1=CC(C2=C(OP3OC4=C(C=C(C)C=C4C)C4=C(O3)C(C)=CC(C)=C4)C(C(C)(C)C)=CC(OC)=C2)=C(OP2OC3=C(C=C(C)C=C3C)C3=C(O2)C(C)=CC(C)=C3)C(C(C)(C)C)=C1.COC1=CC(C2=CC(C)=CC(C(C)(C)C)=C2OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)=C(OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)C(C(C)(C)C)=C1.COC1=CC(C2=CC(OC)=CC(C(C)(C)C)=C2OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)=C(OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)C(C(C)(C)C)=C1 Chemical compound CC1=CC2=C(OP(OC3=C(C4=C(OP5OC6=C(C=C(C)C=C6C(C)(C)C)C6=C(O5)C(C(C)(C)C)=CC(C)=C6)C(C)=CC(C)=C4)C=C(C)C=C3C)OC3=C2C=C(C)C=C3C)C(C)=C1.COC1=CC(C2=C(OP3OC4=C(C=C(C)C=C4C)C4=C(O3)C(C)=CC(C)=C4)C(C(C)(C)C)=CC(OC)=C2)=C(OP2OC3=C(C=C(C)C=C3C)C3=C(O2)C(C)=CC(C)=C3)C(C(C)(C)C)=C1.COC1=CC(C2=CC(C)=CC(C(C)(C)C)=C2OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)=C(OP2OC3=CC=CC=C3C3=C(C=CC=C3)O2)C(C(C)(C)C)=C1.COC1=CC(C2=CC(OC)=CC(C(C)(C)C)=C2OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)=C(OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)C(C(C)(C)C)=C1 UGOJBNLWHOIITI-UHFFFAOYSA-N 0.000 description 1
- FXWURAPZJKNSSW-UHFFFAOYSA-N CC1=CC2=C(OP(OC3=C(C4=C(OP5OC6=C(C=C(C)C=C6C(C)(C)C)C6=C(O5)C(C(C)(C)C)=CC(C)=C6)C(C)=CC(C)=C4)C=C(C)C=C3C)OC3=C2C=C(C)C=C3C)C(C)=C1.COC1=CC(C2=C(OP3OC4=C(C=C(C)C=C4C)C4=C(O3)C(C)=CC(C)=C4)C(C(C)(C)C)=CC(OC)=C2)=C(OP2OC3=C(C=C(C)C=C3C)C3=C(O2)C(C)=CC(C)=C3)C(C(C)(C)C)=C1.COC1=CC(C2=CC(OC)=CC(C(C)(C)C)=C2OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)=C(OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)C(C(C)(C)C)=C1 Chemical compound CC1=CC2=C(OP(OC3=C(C4=C(OP5OC6=C(C=C(C)C=C6C(C)(C)C)C6=C(O5)C(C(C)(C)C)=CC(C)=C6)C(C)=CC(C)=C4)C=C(C)C=C3C)OC3=C2C=C(C)C=C3C)C(C)=C1.COC1=CC(C2=C(OP3OC4=C(C=C(C)C=C4C)C4=C(O3)C(C)=CC(C)=C4)C(C(C)(C)C)=CC(OC)=C2)=C(OP2OC3=C(C=C(C)C=C3C)C3=C(O2)C(C)=CC(C)=C3)C(C(C)(C)C)=C1.COC1=CC(C2=CC(OC)=CC(C(C)(C)C)=C2OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)=C(OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)C(C(C)(C)C)=C1 FXWURAPZJKNSSW-UHFFFAOYSA-N 0.000 description 1
- BYJOHLRBFVMXPE-UHFFFAOYSA-N COC1=CC(C2=CC(OC)=CC(C(C)(C)C)=C2OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)=C(OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)C(C(C)(C)C)=C1 Chemical compound COC1=CC(C2=CC(OC)=CC(C(C)(C)C)=C2OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)=C(OP2OC(C3=CC=CC=C3)(C3=CC=CC=C3)C(C3=CC=CC=C3)(C3=CC=CC=C3)O2)C(C(C)(C)C)=C1 BYJOHLRBFVMXPE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65746—Esters of oxyacids of phosphorus the molecule containing more than one cyclic phosphorus atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1845—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
- B01J31/185—Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
- C07C5/02—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/32—Addition reactions to C=C or C-C triple bonds
- B01J2231/321—Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/32—Addition reactions to C=C or C-C triple bonds
- B01J2231/322—Hydrocyanation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- C07C2531/22—Organic complexes
Definitions
- the invention relates to a process for the purification of a contaminated organophosphorus product which comprises at least one organophosphorus compound and, as contaminant, at least one chlorine compound. Furthermore, the invention relates to a process for producing a catalyst system, in the course of which a contaminated organophosphorus product is purified, and also to a process for hydroformylation or for the hydrocyanation or for the hydrogenation of unsaturated compounds in the presence of a homogeneous catalyst system whose ligand has been purified in this way.
- Organophosphorus compounds are chemical compounds which comprise primarily the elements carbon, hydrogen and phosphorus. Optionally they also comprise oxygen and nitrogen. In addition, the organophosphorus compounds can comprise further elements such as halogens, sulfur etc. in the form of substituents. The term here includes both those organophosphorus compounds which have a P—C bond, as well as those without P—C bond, i.e. with a P—O or a P—N bond.
- Organophosphorus compounds have gained considerable industrial significance because of their wide range of use. They are used directly as plasticizers, flame retardants, UV stabilizers or as antioxidants. In addition, they are important intermediates in the production of fungicides, herbicides, insecticides and pharmaceuticals.
- phosphines, phosphites and phosphoramidites are used as ligands in catalyst complexes, which are used in turn for the homogeneous catalysis of processes operated on an industrial scale.
- hydroformylation of unsaturated compounds with carbon monoxide and hydrogen which generally takes place in the presence of a homogeneous catalyst system which has a metal and at least one organophosphorus compound as ligand.
- the desired organophosphorus compound is never obtained in pure form immediately, and is always obtained in contaminated form as an organophosphorus product which, as well as the desired organophosphorus compound, also contains contaminants.
- the contaminants are unconverted or incompletely converted reagents, auxiliaries or products from side reactions.
- contaminants in the form of chlorine compounds present particular difficulties:
- the pressure reactor is subject to increased corrosion as a result of the chloride. This is especially true of continuous processes, in which the organophosphorus compounds are metered in over the course of the reaction. This is the case, for example, when the organophosphorus compound is used as a ligand in industrial scale hydroformylation.
- the metered addition inevitably also results in an accumulation of the secondary components in the reactor. This is particularly critical if chloride is one of the secondary components since chloride attacks even stainless steels:
- the ready-to-use phosphorus ligands should contain less than 10 000 ppm, better still less than 1 000 ppm total chlorine.
- the risk of stress-cracking corrosion in the reactor can be controlled in industrially implemented processes.
- the aforementioned leaflet considers a chlorine content of 200 ppm to be critical, in industrial chemical processes the organophosphorus compound is only used in catalytic amounts, meaning that the total chlorine content in the reactor is, on account of dilution by the reactants, significantly less than 200 ppm, if the degree of contamination of the ligands used is within the desired range.
- the chloride content can be determined analytically in a simple manner, for example by aqueous titration. A more extensive determination is that of the total chlorine content, which, as well as the chlorides, also encompasses chlorine bound in other forms. Emphasis on the total chlorine content is also of material relevance, in that it cannot be ruled out that chlorine bound in another form is also able to damage the reactor. In judging the limits for total chlorine, however, the chloride fraction remains crucial.
- a suitable method for determining the total chlorine content is the combustion according to Wickbold with sample preparation to DIN 51408 and analysis by ion chromatography to DIN EN ISO 10304.
- EP 0 285 136 claims a process for purifying tertiary organophosphites of pentavalent organophosphorus compounds which form as by-products of the synthesis or else as degradation or hydrolysis products of the tertiary organophosphites.
- the process envisages the treatment of the dissolved contaminated organophosphite with water at elevated temperature in the presence of a Lewis base.
- Lewis bases used are inorganic salts (carbonates, hydroxides, oxides), tertiary amines and polymers which carry amine groups.
- CN 101684130 A discloses the purification of phosphite ligands through the addition of deionized water and subsequent extraction. The organic solvent is removed by distillation in a subsequent step, and the crude product is recrystallized again. In this way, it was possible to obtain a product having a residual chlorine content of 0.01% by weight of chlorine.
- WO 2012 095253 describes a process for preparing 6,6′-[(3,3′-di-tert-butyl-5,5′-dimethoxy-1,1′-biphenyl-2,2′diyl)bis(oxy)]bis(dibenzo[d,f][1,3,2]dioxaphosphepin) (termed: “biphephos”).
- the purification of the ligand takes place by repeated washing with various solvents.
- EP2091958B1 describes the preparation of bisphosphites which are obtained dissolved in toluene and are filtered. This results merely in a partial removal of the chlorine, which is in need of improvement with regard to the intended use of the prepared organophosphorus compound as ligand in the hydroformylation of olefins.
- a combination of filtration and recrystallization for the purification of biphephos is shown in WO 2012/095255A1.
- a solid organophosphorus product is slurried in a solvent and filtered by means of a frit.
- the resulting, again solid organophosphorus product comprised, besides the desired biphephos, 2500 ppm of total chlorine.
- the solid was suspended in a solvent, heated and filtered. Then, the filtrate was recrystallized.
- the resulting purified organophosphorus product had a total chlorine content of only 35 ppm.
- the invention is based on the object of indicating an industrially practicable purification method in which the chlorine content of an organophosphorus product which comprises at least one organophosphorus compound and at least one chlorine compound as contaminant, can be reduced from originally 1000 to 100,000 ppm to a total chlorine content between 10 ppm and 10,000 ppm.
- the desired chlorine contents here are understood as total chlorine content, i.e. both organically bonded chlorine and inorganically bonded chlorine.
- the unit ppm stands for 10 ⁇ 6 and refers to the respective weights.
- the purification process should dispense with the use of water on account of the hydrolysis stability of the organophosphites.
- the invention therefore provides a process for the purification of a contaminated organophosphorus product which comprises at least one organophosphorus compound and, as contaminant, at least one chlorine compound, having the steps a) to d).
- the purification according to the invention takes place by means of a membrane and/or by means of a filter.
- a membrane and/or by means of a filter.
- the purification process makes do without water and without undue consumption of solvents. Nevertheless, the solvent constitutes an important element of the invention, since the contaminated organophosphorus compound has to be completely dissolved in the solvent before the purification by means of filter and/or membrane separation unit.
- the complete dissolution of the organophosphorus product is an essential distinguishing feature of the present invention compared to other filtration processes, such as for example the processes known from EP2091958B1 or WO 2012/095255A1:
- a “complete dissolution” of the contaminated organophosphorus product is to be understood as meaning that both the desired organophosphorus compound and the undesired chlorine compounds are dissolved in their entirety in the solvent. Consequently, solid must no longer be visible in the solution.
- the visual test suffices for the success desired according to the invention. Of course, residual particles can still be detected in an optically complete solution with suitable, objective measurement methods. However, the process according to the invention should also be able to be practised easily. Consequently, a visual test is considered to be a satisfactory criterion for the assessment of a complete solution in the context of the invention.
- the complete dissolution of the contaminated organophosphorus product including the chlorine soiling in the solvent permits a more selective separation of the organophosphorus compound from the chlorine compound on the filter or on the membrane.
- a purified solution is produced from which the chlorine compound is depleted.
- a purified organophosphorus product is obtained whose total chlorine content is significantly lower than that of the originally provided, contaminated organophosphorus product.
- the removed solvent can be recycled and be used again for dissolving contaminated organophosphorus product.
- the disposal expenditure for the solvent drops as a result.
- organophosphorus compounds takes place in a suspension or a slurry. It makes little sense to isolate the organophosphorus product from the suspension or from the slurry and then to dissolve it again in the solvent. Particularly when the synthesis of the organophosphorus product and its purification takes place at the same site and/or even in the same apparatus, it makes more sense to carry out the two steps
- the two steps a) and b) then take place at practically the same time. If the synthesis of the organophosphorus product takes place in suspension, i.e. in the case of incompletely dissolved organophosphorus product, the complete dissolution can inter alia be achieved by adding further solvent or increasing the temperature.
- a contaminated organophosphorus product in solid form i.e. amorphous or crystalline
- the solvent used for the purpose of purification is a different solvent to the one used during the synthesis of the organophosphorus product.
- the purification process according to the invention serves to free the contaminated organophosphorus product from its chlorine-containing contaminants.
- the separation off of the chlorine compounds takes place following complete dissolution of the contaminated organophosphorus product with all of its contaminants in the solvent. It therefore goes without saying that the total chlorine content of the purified solution is lower than that of the total chlorine content of the contaminated solution.
- the contaminated solution is accordingly purified of the chlorine compounds dissolved therein. As a result, the purified solution is obtained.
- a more heavily contaminated solution is obtained in which the undesired contaminants are enriched.
- the total chlorine content of the more contaminated solution is accordingly greater than the total chlorine content of the contaminated solution.
- the process according to the invention makes it possible to reduce the total chlorine content of a contaminated organophosphorus product, which is between 1000 and 100,000 ppm, in the purified state to a value between 10 and 10,000 ppm.
- the purification process leads to a total chlorine content of the purified organophosphorus product between 10 and 1000 ppm.
- the unit ppm stands here for one millionth of a weight fraction.
- the total chlorine content includes both organic and inorganic species.
- a suitable method for determining the total chlorine content is the combustion according to Wickbold with sample preparation to DIN 51408 and analysis by ion chromatography to DIN EN ISO 10304.
- the contaminated organophosphorus product can contain organic chlorides and/or inorganic chlorides.
- Organic chlorides contain at least one carbon atom, whereas inorganic chlorides do not include any carbon. Contamination of the organophosphorus product by the following chlorides is particularly likely, since these chlorine compounds are either required in the course of synthesis of organophosphorus compounds or are unavoidably produced as by-products:
- the contaminated organophosphorus product preferably has at least one of the listed chlorides.
- the solvent selected is a substance which is able to dissolve both the organophosphorus compound as well as the chlorine-containing contaminant. Otherwise, a complete dissolution of the contaminated organophosphorus product therein would not be possible.
- Solvents that can be used are either a pure substance from the list below, or else a mixture of two or more substances from this group:
- the just mentioned solvents are organic solvents.
- the contaminated solution i.e. the contaminated organophosphorus product completely dissolved in the organic solvent, consequently forms an organic phase. Since the process is preferably carried out in the absence of water on account of the susceptibility to hydrolysis of the organophosphorus products, no aqueous phase is formed alongside the organic phase. On account of the complete dissolution, the contaminated solution is solid-free.
- the organic phase formed by the contaminated solution is therefore the single phase in the system formed from organophosphorus product, contaminant and solvent.
- a complete dissolution of the contaminated organophosphorus product at room temperature is not always possible.
- a preferred development of the invention envisages dissolving the contaminated organophosphorus product at elevated temperature.
- the temperature here should be selected such that the solvent still does not start to boil.
- the temperature of the solvent used should therefore be between 20° C. and the boiling temperature of the selected solvent. Optimally, the temperature range is from 40° C. to 120° C.
- the increase in the temperature of the solvent also makes it possible to reduce the amount of solvent. This is particularly advantageous if a solvent that is harmful to health, environmentally impactful or simply expensive is used.
- the separation of the contaminated solution takes place by means of a filter.
- a filter separates predominantly mechanically according to the sieve effect, i.e. selectively according to the particle size.
- adsorption effects also play a role.
- the undesired chlorine compounds are unable to pass through the filter and therefore accumulate on this side of the filter in the filter cake.
- the chlorine-containing contaminants are depleted. Therefore, the purified solution is produced behind the filter as filtrate.
- Suitable filters are both surface filters and also deep-bed filters. It is possible to use frits, filter candles, filter bags or filter cloths.
- the filters can be produced from ceramic or from plastics such as polypropylene.
- a particularly preferred embodiment of the filtration variant envisages that the separation of the contaminated solution is carried out in the presence of a filtration auxiliary.
- the filtration auxiliary is added to the solvent for this purpose either directly before the filtration of the contaminated solution or even earlier.
- Filtration aids bind the contaminants to be separated off in part physically and thereby prevent the filter being overcome.
- the particles to be separated off form a layer on the filter surface and form bridges via the pores in the filter. Only these bridges in most cases bring about a complete separation of the particles. At the start there is therefore usually also leakage of the particles.
- the partial filtration with filter auxiliaries here has the advantage of building up these bridges already with the filter auxiliary and of preventing leakage of the particles from the product mixture.
- Filtration aids used may be either mineral filtration aids, for example silicon dioxide, or organic filtration aids, for example cellulose or activated carbon. It is also possible to mix different filtration aids.
- the separation of the contaminated solution takes place by means of a membrane separation unit.
- the membrane separation is based not only on the sieve effect, but moreover also on dissolution and diffusion effects.
- a further difference compared to filtration is that the substances to be separated off by means of membrane technology can completely overcome the membrane; however, this only at a reduced rate.
- the selective separation in practice in most cases additionally requires the establishment of corresponding overflow rates.
- a membrane separation also presupposes a clear pressure gradient between both sides of the membrane, the so-called transmembrane pressure, whereas in the case of filtration the pressure loss is considerably less.
- a transmembrane pressure is not always inevitably required, for example if the driving force results from a unbalanced dissolution equilibrium (reverse osmosis).
- a membrane separation is consequently significantly more complex and technically demanding than a filtration. Nevertheless, it allows the removal of contaminants which cannot be removed in the course of a classic filtration.
- Retentate is the term used in membrane technology to refer to the material stream from a membrane separation unit which, from the view of the inflowing feed, is drawn off in front of the membrane.
- the material stream which is drawn off behind the membrane is referred to as permeate since it has overcome the membrane.
- the membrane separation unit can contain a multiplicity of membrane modules which can be connected to one another in different ways.
- the customary module connections are contemplated here, as for example Melin/Rautenbach describe.
- the membrane modules themselves can be configured constructively in different variants, for example as pocket modules, plate modules, coil modules, hollow fibre modules, capillary modules or hose modules.
- process parameters of the membrane separation also have an influence on the separation result.
- Important operating parameters are the selected solvent, the transmembrane pressure and the overflow rate. The membrane technologist knows how to suitably select these operating parameters.
- the separation temperature i.e. the temperature at which the contaminated solution is placed on the membrane. This is because the permeability of many membrane materials is dependent on the temperature. Since the temperature of the solvent during the dissolution of the contaminated organophosphorus product is likewise attributed major significance, a preferred development of the invention envisages that the membrane separation takes place at a temperature which deviates from the temperature during the complete dissolution of the contaminated organophosphorus product with solvent. Accordingly, between step b) and step c) either a deliberate heating or a deliberate cooling of the contaminated solvent takes place. Whether cooling or heating specifically has to be carried out depends on the solvent used, the organophosphorus compounds and chlorides dissolved therein, and also the separation-active membrane material. As a rule, the separation of the contaminated solution by means of the membrane separation unit will take place at a temperature of 10 to 80° C., particularly preferably 20 to 60° C.
- organophosphorus compounds which are used for the most diverse of purposes. Freedom from chlorine can therefore be a greater or lesser priority for different intended uses of the various organophosphorus compounds. Particularly high requirements are placed on the total chlorine content of organophosphorus products wherever the actual organophosphorus compound is used as ligand in a homogeneously catalysed, continuously operated reaction whose reaction apparatuses are damaged by chlorides.
- Organophosphorus compounds which are typically used as ligands in homogeneous catalyst systems are phosphines, diphosphines, phosphonites, phosphinites, phosphoramidites, monophosphites and bisphosphites.
- the purification process according to the invention is therefore used in particular in connection with the synthesis of these classes of substance.
- the bisphosphites serves for the purification of organophosphorus products which comprise phosphoramidites or phosphites. It is in particular intended for purifying bisphosphites, it being particularly suitable for the purification of the bisphosphites of the structural formulae (I) to (IV):
- a process for producing a catalyst system comprising a metal and at least one organophosphorus compound as ligand is likewise provided by the invention, provided that in the production of the catalyst system an organophosphorus product purified according to the invention is used which comprises those organophosphorus compounds which are typically used as ligand in catalyst systems.
- the production of the catalyst system takes place in most cases not at the site at which the ligand synthesis also takes place, but in situ, i.e. where the catalyst system is used, namely in the reactor.
- the catalyst system is produced here by introducing the organophosphorus product produced ex situ and purified according to the invention into the reactor together with the metal.
- the actual catalyst system is formed only in the reactor in the presence of the reactants.
- the implementation of reactions in reactors which react particularly sensitively to the removed chlorides is likewise provided by the invention, specifically when unsaturated compounds are hydroformylated or hydrocyanated or hydrogenated in the presence of a homogeneous catalyst system, provided the catalyst system has a metal and at least one organophosphorus compound as ligand, and provided during the production of the catalyst system the corresponding organophosphorus product has been purified according to the invention.
- Particularly at risk are reactors made of steel, meaning that the purification process is in particular then advantageously used if the catalysed reaction takes place in a steel apparatus.
- the resulting solid was filtered and washed four times with 200 ml of degassed ACN. The remaining solvent was removed at 10 ⁇ 1 mbar for 3 h at 40° C. under reduced pressure and 43.9 g (88%) of the crude ligand (III) were obtained.
- the retentate produced had a chlorine value, determined according to Wickbold, of 55 mg/kg.
- the chlorine value was thus able to be reduced for a ligand yield of 81.2% by 99.9%.
- the organophosphorus compound 4,8-di-tert-butyl-2,10-dimethoxy-6-((3,3′,5,5′-tetramethyl-2′-((2,4,8,10-tetramethyldibenzo[d,f][1,3,2]dioxaphosphepin-6-yl)oxy)-[1,1′-biphenyl]-2-yl)oxy)dibenzo[d,f][1,3,2]dioxaphosphepine, with the structural formula (I)
- ligand (I) is referred to here as ligand (I).
- the synthesis of this ligand was carried out according to the instructions in the German patent applications 102013219506.0 and 102013219508.7 which were still unpublished at the time of the application:
- the biphenol (2) used as a precursor was prepared by the following synthesis method.
- This solid was suspended in degassed ACN at 75° C. for 1.5 h and separated off and after-washed with warm ACN. Subsequently, the product was suspended in dried toluene at 35° C. for 1.5 h and separated off.
- the filtrate was again filtered under inert conditions through a filter bed from PALL of the type Seitz® K 100 with an area of 20 cm 2 .
- a sample of the generated filtrate produced the following chlorine value, determined according to Wickbold: 820 mg/kg.
- the remaining filtrate of 1550 g was finally separated in a stirred dead-end separating cell from Evonik Membrane Extraction Technology Limited of the type METCELL® with a nanofiltration membrane.
- An organophilic nanofiltration membrane from GMT Membrantechnik GmbH of the type ONF-2 was used.
- the membrane area is 54 cm 2 .
- the active membrane area is installed facing the feed.
- the permeate flows away through the sintered metal plate of the separating cell via the permeate outlet.
- the membrane separation was carried out at 27° C. and a nitrogen pressure of 30 bar. 1137 g of permeate were produced. This corresponds to a volumetric concentration factor of 3.8.
- the permeate produced comprises 8 g of solid and also a chlorine value according to Wickbold of 880 mg/kg and comprised in particular the chlorine-containing contaminants as main constituent.
- the retentate produced comprises 38 g of solid and also a chlorine value according to Wickbold of 260 mg/kg.
- the chlorine value was thus able to be reduced by 98%.
- the Cl value of the filtrate produced was 190 mg/kg.
- the chlorine value was thus able to be reduced for a ligand yield of 77.6% by more than 99%.
- This crude solution already comprises the filter aid VITACEL® LC 200, consisting of cellulose.
- Crude solution was transferred to a nitrogen-flushed 2-liter pressure filtration device with a filter area of 130 cm 2 and filtered through the filter cloth Propex 14K.
- the filtration temperature was 20° C. and the filtration pressure was 2 bar.
- the filtrate was again filtered under inert conditions through a filter bed from PALL of the type Seitz® K 100 with an area of 20 cm 2 .
- the filtrate produced gave a chlorine value, determined by X-ray fluorescence analysis (XRFA), of 0.15% by weight.
- the chlorine value was thus able to be reduced for a ligand yield of 88.2% by 85%.
- the filtrate was again filtered under inert conditions through a 1′′ filter candle from PALL of the type Profile® II with a separation limit of 0.3 ⁇ m. From the filtrate produced, the following chlorine value, ascertained with X-ray fluorescence analysis (XRFA), was determined: 0.26% by weight.
- XRFA X-ray fluorescence analysis
- the remaining filtrate was finally separated in a 2 l pressure filter device through an ultrafiltration membrane from Microdyn Nadir of the type UV150T at 20° C. and 2 bar.
- the retentate produced revealed a chlorine value, determined with X-ray fluorescence analysis (XRFA), of 0.12% by weight.
- the chlorine value was thus able to be reduced for a ligand yield of 63% by 96.6%.
- ligand (IV) is also referred to as biphephos and hereinbelow as ligand (IV).
- the retentate had a chlorine value, determined according to Wickbold, of 30 mg/kg.
- the chlorine value was thus able to be reduced for a ligand yield of 32.1 g by 83%.
- the retentate produced had a chlorine value, determined according to Wickbold, of less than 10 mg/kg.
- the chlorine value was thus able to be reduced for a ligand yield of 64.4 g by 94%.
- the filtrate was again filtered under inert conditions through a filter bed from PALL of the type Seitz® K 100 with an area of 20 cm 2 .
- the retentate produced had a chlorine value, determined according to Wickbold, of 28 mg/kg.
- the chlorine value was thus able to be reduced for a ligand yield of 31.2 g by 84%.
- the experiments show that it is possible with the described purification methods to free contaminated organophosphorus products from chlorine compounds to a significant degree.
- the thus purified organophosphorus compounds can be used without reservation as ligands in industrially operated reactions, since corrosion of steel apparatuses is no longer to be feared on account of their low total chlorine content.
- the organophosphorus compounds under consideration themselves have proven their value as ligands in homogeneously catalysed hydroformylation.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
-
- a) provision of the contaminated organophosphorus product;
- b) complete dissolution of the contaminated organophosphorus product in a solvent to give a contaminated solution;
- c) separation of the contaminated solution by means of a filter and/or by means of a membrane separation unit to give a purified solution;
- d) removal of the solvent from the purified solution to give a purified organophosphorus product.
Description
- B. CORNILS, W. A. HERRMANN: Applied Homogeneous Catalysis with Organometallic Compounds. Vol. 1 & 2, VCH, Weinheim, N.Y., 1996
- R. Franke, D. Selent, A. Borner: Applied Hydroformylation. Chem. Rev., 2012, DOI:10.1021/cr3001803
- “Phosphorous(III) Ligands in Homogeneous Catalysis—Design and Synthesis” by Paul C. J. Kamer and Piet W. N. M. van Leeuwen; John Wiley and Sons, 2012.
- Merkblatt [Information sheet] 893 “Edelstahl rostfrei für die Wasserwirtschaft” [Corrosion-free stainless steel for water management], 1st edition 2007, publisher: Informationsstelle Edelstahl Rostfrei, Dusseldorf.
- a) provision of the contaminated organophosphorus product;
- b) complete dissolution of the contaminated organophosphorus product in a solvent to give a contaminated solution;
- c) separation of the contaminated solution by means of a filter and/or by means of a membrane separation unit to give a purified solution;
- d) removal of the solvent from the purified solution to give a purified organophosphorus product.
-
- a) provision of the contaminated organophosphorus product;
- and
- b) complete dissolution of the contaminated organophosphorus product in a solvent to give a contaminated solution;
together in one operation in which the contaminated organophosphorus product is provided completely dissolved in the contaminated solution.
-
- phosphorus trichloride, chlorophosphites, dichlorophosphites, hydrochlorides of amines, hydrochlorides of alkali metals, chlorides of alkaline earth metals, chlorine-containing acids obtainable from the hydrolysis of phosphorus trichloride.
-
- aromatic hydrocarbons such as in particular toluene, xylene, o-xylene, cresol;
- ethers, such as in particular tetrahydrofuran (THF), petroleum ether, diethyl ether, methyl tert-butyl ether (MTBE);
- nitriles such as in particular acetonitrile (ACN);
- ethyl acetate;
- acetone;
- alcohols such as in particular methanol, ethanol, isopropanol, butanol.
- Pongratz et al., Handbuch der industriellen Fest-/Flüssigfiltration [Handbook of industrial solid/liquid filtration] (2000);
- Sparks, Trevor: Solid-Liquid Filtration—A Users' Guide to Minimizing Costs and Environmental Impact; Maximizing Quality and Productivity. Elsevier (2012);
- Cheremisinoff, Nicholas P.: Liquid Filtration (2nd Edition). Elsevier (1998)
- Sutherland: Filters and Filtration Handbook (2008).
- Melin/Rautenbach: Membranverfahren. Grundlagen der Modul—and Anlagenauslegung. [Membrane Processes. Fundamentals of Module and System Design] Springer, Berlin Heidelberg 2004.
-
- ACN=acetonitrile
- CPG=core-pulled precision glass
- DM water=demineralized water
- EtOAc=ethyl acetate
- acac=acetylacetonate
- NEt3=triethylamine
- DMAB=dimethylaminobutane
- KOtBu=potassium tert-butylate
- RT=room temperature
is referred to here as ligand (I). The synthesis of this ligand was carried out according to the instructions in the German patent applications 102013219506.0 and 102013219508.7 which were still unpublished at the time of the application:
Claims (15)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014201756.4 | 2014-01-31 | ||
| DE102014201756.4A DE102014201756A1 (en) | 2014-01-31 | 2014-01-31 | Purification of chlorine-contaminated organophosphorus compounds |
| DE102014201756 | 2014-01-31 | ||
| PCT/EP2015/050778 WO2015113840A1 (en) | 2014-01-31 | 2015-01-16 | Purifying organophosphorous compounds contaminated with chlorine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20160326197A1 US20160326197A1 (en) | 2016-11-10 |
| US9676805B2 true US9676805B2 (en) | 2017-06-13 |
Family
ID=52432793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/109,745 Active US9676805B2 (en) | 2014-01-31 | 2015-01-16 | Purifying organophosphorus compounds contaminated with chlorine |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9676805B2 (en) |
| EP (1) | EP3099700B1 (en) |
| CN (1) | CN105940006B (en) |
| DE (1) | DE102014201756A1 (en) |
| TW (1) | TW201542576A (en) |
| WO (1) | WO2015113840A1 (en) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245578B2 (en) | 2016-11-09 | 2019-04-02 | Evonik Degussa Gmbh | Chromium- and nickel-free hydrogenation of hydroformylation mixtures |
| US10501392B2 (en) | 2017-12-01 | 2019-12-10 | Evonik Degussa Gmbh | Method for obtaining alcohols from aldehydes II |
| US10562833B2 (en) | 2017-12-01 | 2020-02-18 | Evonik Degussa Gmbh | Method for obtaining alcohols from aldehydes III |
| US10577297B2 (en) | 2017-12-01 | 2020-03-03 | Evonik Operations Gmbh | Method for obtaining alcohols from aldehydes |
| US10633302B2 (en) | 2018-07-25 | 2020-04-28 | Evonik Operations Gmbh | Process for oligomerization of butene with determination of the proportion of acidic catalysis |
| US10647650B2 (en) | 2018-10-05 | 2020-05-12 | Evonik Operations Gmbh | Process for hydroformylating short-chain olefins using a heterogenized catalyst system without ionic liquid |
| US10654784B2 (en) | 2018-10-05 | 2020-05-19 | Evonik Operations Gmbh | Process for hydroformylating short-chain olefins in the gas phase |
| US10850261B2 (en) | 2018-03-14 | 2020-12-01 | Evonik Operations Gmbh | Oligomerization catalyst and process for the production thereof |
| US10882028B2 (en) | 2018-03-14 | 2021-01-05 | Evonik Operations Gmbh | Ni-containing catalyst for the oligomerization of olefins |
| US10882027B2 (en) | 2018-03-14 | 2021-01-05 | Evonik Operations Gmbh | Process for producing an oligomerization catalyst |
| US11008275B2 (en) | 2019-06-12 | 2021-05-18 | Evonik Operations Gmbh | Process for preparing carboxylic acids or salts thereof from hydrocarbons |
| US11027266B2 (en) | 2016-11-08 | 2021-06-08 | Evonik Operations Gmbh | Phosphorous acid P,P′-[5,5′,6,6′-tetramethyl-3,3′-bis(l- methylethyl)[1,1′-biphenyl]-2,2′-diyl] P,P,P′,P'-tetrakis(2,4-dimethylphenyl) ester in hydroformylation |
| US11253844B2 (en) | 2018-03-14 | 2022-02-22 | Evonik Operations Gmbh | Oligomerization catalyst and process for the production thereof |
| US11365171B2 (en) | 2019-06-12 | 2022-06-21 | Evonik Operations Gmbh | Process for preparing an ester by alkoxycarbonylation |
| US11440863B2 (en) | 2019-06-12 | 2022-09-13 | Evonik Operations Gmbh | Process for preparing an alcohol from hydrocarbons |
| US11519020B2 (en) | 2018-05-25 | 2022-12-06 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
| US11769597B2 (en) | 2015-12-03 | 2023-09-26 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
| US12064755B2 (en) | 2019-06-12 | 2024-08-20 | Evonik Oxeno Gmbh & Co. Kg | Process for separating one or more components from a mixture |
| US12246310B2 (en) | 2019-11-05 | 2025-03-11 | Dow Technology Investments Llc | Processes for recovery of rhodium from a hydroformylation process |
| US12337276B2 (en) | 2019-02-01 | 2025-06-24 | Evonik Operations Gmbh | Device and a membrane process for separating gas components from a gas stream having varying composition or flow rate |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102013215004A1 (en) | 2013-07-31 | 2015-02-05 | Evonik Industries Ag | Membrane cascade with decreasing separation temperature |
| DE102014202500A1 (en) | 2014-02-12 | 2015-08-13 | Evonik Degussa Gmbh | Process for reducing the chlorine content of organobisphosphites |
| EP3147291A1 (en) | 2015-09-28 | 2017-03-29 | Evonik Degussa GmbH | Method for reducing the chlorine content of organo tetraphosphites |
| ES2765635T3 (en) | 2016-05-19 | 2020-06-10 | Evonik Operations Gmbh | Production of n-pentanal from mixtures of butene-poor use substances |
| CN107915758B (en) * | 2017-11-15 | 2019-10-29 | 万华化学集团股份有限公司 | Phosphoramidite ligand, catalyst and the method for preparing 4- acetoxyl group butyraldehyde |
| EP4180439A1 (en) * | 2021-11-15 | 2023-05-17 | Evonik Operations GmbH | Method for reducing the chlorine content of organobisphosphites by means of inert gas frit |
Citations (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0285136A2 (en) | 1987-03-31 | 1988-10-05 | Union Carbide Corporation | Process for purifying tertiary organophosphites |
| WO2001021627A1 (en) | 1999-09-20 | 2001-03-29 | E.I. Du Pont De Nemours And Company | Hydroformylation using multidentate phosphite ligands |
| EP1097936A1 (en) | 1999-11-02 | 2001-05-09 | Ciba SC Holding AG | Process for the preparation of low chloride stabilisers |
| US6350819B1 (en) | 2000-10-27 | 2002-02-26 | Union Carbide Chemicals & Plastics Technology Corporation | Dendritic macromolecules for metal-ligand catalyzed processes |
| US6469145B1 (en) * | 2000-06-26 | 2002-10-22 | The United States Of America As Represented By The Secretary Of The Army | One-step purification process for organophosphorus hydrolase enzyme |
| US6472550B1 (en) | 1999-11-02 | 2002-10-29 | Ciba Specialty Chemicals Corporation | Process for the preparation of low chloride stabilizers |
| DE102004049339A1 (en) | 2004-10-08 | 2006-04-13 | Basf Ag | Process for the purification of phosphorus-containing chelate ligands |
| US7345185B2 (en) | 2003-12-23 | 2008-03-18 | Oxeno Olefinchemie Gmbh | Method for producing organoacylphosphites |
| DE102006058682A1 (en) | 2006-12-13 | 2008-06-19 | Evonik Oxeno Gmbh | Bisphosphite ligands for transition metal-catalyzed hydroformylation |
| EP2003138A1 (en) | 2006-04-04 | 2008-12-17 | Kuraray Co., Ltd. | Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite |
| CN101684130A (en) | 2008-09-25 | 2010-03-31 | 上海焦化有限公司 | Preparation method of phosphite ester |
| US7767861B2 (en) | 2003-12-23 | 2010-08-03 | Evonik Oxeno Gmbh | Method for producing trivalent organophosphorus compounds |
| WO2012095255A1 (en) | 2011-01-13 | 2012-07-19 | Evonik Oxeno Gmbh | Method for the purification of biphephos |
| WO2012095253A1 (en) | 2011-01-13 | 2012-07-19 | Evonik Oxeno Gmbh | Method for producing biphephos |
| US8609878B2 (en) | 2008-11-07 | 2013-12-17 | Evonik Oxeno Gmbh | Method for producing 6-chlorodibenzo[D,F] [1 3,2]Dioxaphosphepin |
| DE102013219506A1 (en) | 2012-10-12 | 2014-04-17 | Evonik Degussa Gmbh | New 4,8-di-tert-butyl-2,10-dimethoxy-6-(3,3',5,5'-tetramethyl-2'-(2,4,8,10-tetramethyldibenzo(d,f)(1,3,2)dioxaphosphepin-6-yloxy)biphenyl-2-yloxy)dibenzo(d,f)(1,3,2)dioxaphosphepine useful as catalyst to hydroformylate unsaturated compound |
| DE102013219508A1 (en) | 2012-10-12 | 2014-04-17 | Evonik Degussa Gmbh | Mixture useful as a catalyst for hydroformylating unsaturated compound or its mixture, comprises e.g. 6,6'-(3,3'-di-tert-butyl-5,5'-dimethoxybiphenyl-2,2'-diyl)bis(oxy)bis(2,4,8,10-tetramethyldibenzo(d,f)(1,3,2)dioxaphosphepine) |
| WO2014056735A1 (en) | 2012-10-12 | 2014-04-17 | Evonik Degussa Gmbh | Mixture of constitutional isomer bisphosphites |
| US8729287B2 (en) | 2008-11-07 | 2014-05-20 | Evonik Oxeno Gmbh | Method for producing 6-chlorodibenzo[d,f] [1,3,2]-dioxaphosphepin |
| US20140309423A1 (en) | 2011-11-08 | 2014-10-16 | Evonik Degussa Gmbh | Novel organophosphorus compounds based on anthracenetriol |
| WO2014177355A1 (en) | 2013-05-03 | 2014-11-06 | Evonik Industries Ag | New quadridentate phosphorus ligands comprising hostanox o3 conductive structure |
| US20150011139A1 (en) | 2009-01-16 | 2015-01-08 | Zeus Industrial Products, Inc. | Electrospinning of ptfe with high viscosity materials |
| US20150011132A1 (en) | 2012-02-03 | 2015-01-08 | Jx Nippon Mining & Metals Corporation | Press-fit terminal and electronic component using the same |
| US9000220B2 (en) | 2009-08-31 | 2015-04-07 | Evonik Degussa Gmbh | Organophosphorus compounds based on tetraphenol (TP)-substituted structures |
| WO2015121007A1 (en) | 2014-02-12 | 2015-08-20 | Evonik Degussa Gmbh | Method for reducing the chlorine content of organobisphosphites |
| WO2015176927A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Degussa Gmbh | Method for reducing the chlorine content of organomonophosphites using two solutions |
| US20150336865A1 (en) | 2014-05-26 | 2015-11-26 | Evonik Degussa Gmbh | Process for preparing 2,2'-biphenols using selenium dioxide |
| US20150336885A1 (en) | 2014-05-26 | 2015-11-26 | Evonik Degussa Gmbh | Process for preparing 2,2'-selenobiaryl ethers or 4,4'-selenobiaryl ethers using selenium dioxide |
| US20150336093A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Industries Ag | Process for catalytic preparation of aldehydes from olefins using monophosphite mixtures |
| US20150336995A1 (en) | 2014-05-26 | 2015-11-26 | Evonik Degussa Gmbh | Process for preparing 2,2'-biphenols using selenium dioxide and halogenated solvent |
| US20150336861A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Degussa Gmbh | Preparation of high-quality oxo process alcohols from inconstant raw material sources |
| WO2015181018A1 (en) | 2014-05-26 | 2015-12-03 | Evonik Degussa Gmbh | Method for producing asymmetrical biphenols using selenium dioxide |
| US9212195B1 (en) | 2014-05-20 | 2015-12-15 | Evonik Industries Ag | Monophosphite ligands having a carbonate group |
| US9217003B2 (en) | 2014-02-12 | 2015-12-22 | Evonik Industries Ag | Preparation of 6,6′-((3,3′-di-tert-butyl-5,5′-dimethoxy-[1,1′-biphenyl]-2,2′-diyl)bis(oxy))bis(2,4,8,10-tetramethyldibenzo[d,f][1,3,2]dioxaphosphepine) |
| US9221850B2 (en) | 2014-05-20 | 2015-12-29 | Evonik Industries Ag | Monophosphite ligands having a tert-butyloxycarbonyl group |
| US9221851B2 (en) | 2014-05-20 | 2015-12-29 | Evonik Industries Ag | Mixture containing a monophosphite ligand and the use thereof for catalysis of a hydroformylation reaction |
| US20160010225A1 (en) | 2013-03-07 | 2016-01-14 | Evonik Degussa Gmbh | Electrochemical coupling of two phenols which differ in their oxidation potential |
| US20160010226A1 (en) | 2013-03-07 | 2016-01-14 | Evonik Degussa Gmbh | Electrochemical coupling of anilines |
| US20160017505A1 (en) | 2013-03-07 | 2016-01-21 | Evonik Degussa Gmbh | Electrochemical coupling of a phenol to a naphthol |
| US20160017504A1 (en) | 2013-03-07 | 2016-01-21 | Evonik Degussa Gmbh | Electrochemical process for coupling of phenol to aniline |
-
2014
- 2014-01-31 DE DE102014201756.4A patent/DE102014201756A1/en not_active Withdrawn
-
2015
- 2015-01-16 EP EP15701497.8A patent/EP3099700B1/en active Active
- 2015-01-16 WO PCT/EP2015/050778 patent/WO2015113840A1/en not_active Ceased
- 2015-01-16 CN CN201580006464.6A patent/CN105940006B/en active Active
- 2015-01-16 US US15/109,745 patent/US9676805B2/en active Active
- 2015-01-29 TW TW104103041A patent/TW201542576A/en unknown
Patent Citations (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0285136A2 (en) | 1987-03-31 | 1988-10-05 | Union Carbide Corporation | Process for purifying tertiary organophosphites |
| WO2001021627A1 (en) | 1999-09-20 | 2001-03-29 | E.I. Du Pont De Nemours And Company | Hydroformylation using multidentate phosphite ligands |
| EP1097936A1 (en) | 1999-11-02 | 2001-05-09 | Ciba SC Holding AG | Process for the preparation of low chloride stabilisers |
| US6472550B1 (en) | 1999-11-02 | 2002-10-29 | Ciba Specialty Chemicals Corporation | Process for the preparation of low chloride stabilizers |
| EP1097936B1 (en) | 1999-11-02 | 2003-03-05 | Ciba SC Holding AG | Process for the preparation of low chloride stabilisers |
| DE60001533T2 (en) | 1999-11-02 | 2003-10-02 | Ciba Speciality Chemicals Holding Inc., Basel | Process for the preparation of stabilizers with a low chloride content |
| US6469145B1 (en) * | 2000-06-26 | 2002-10-22 | The United States Of America As Represented By The Secretary Of The Army | One-step purification process for organophosphorus hydrolase enzyme |
| US6350819B1 (en) | 2000-10-27 | 2002-02-26 | Union Carbide Chemicals & Plastics Technology Corporation | Dendritic macromolecules for metal-ligand catalyzed processes |
| US7345185B2 (en) | 2003-12-23 | 2008-03-18 | Oxeno Olefinchemie Gmbh | Method for producing organoacylphosphites |
| US7767861B2 (en) | 2003-12-23 | 2010-08-03 | Evonik Oxeno Gmbh | Method for producing trivalent organophosphorus compounds |
| DE102004049339A1 (en) | 2004-10-08 | 2006-04-13 | Basf Ag | Process for the purification of phosphorus-containing chelate ligands |
| US20080076944A1 (en) | 2004-10-08 | 2008-03-27 | Basf Aktiengesellschaft | Purification of Phosphorus Chelate Ligands |
| EP2003138A1 (en) | 2006-04-04 | 2008-12-17 | Kuraray Co., Ltd. | Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite |
| DE102006058682A1 (en) | 2006-12-13 | 2008-06-19 | Evonik Oxeno Gmbh | Bisphosphite ligands for transition metal-catalyzed hydroformylation |
| EP2091958B1 (en) | 2006-12-13 | 2011-04-27 | Evonik Oxeno GmbH | Bisphosphite ligands for hydroformylation catalyzed by transition metals |
| US8003816B2 (en) | 2006-12-13 | 2011-08-23 | Evonik Oxeno Gmbh | Bisphosphite ligands for hydroformylation catalyzed by transition metals |
| CN101684130A (en) | 2008-09-25 | 2010-03-31 | 上海焦化有限公司 | Preparation method of phosphite ester |
| US20140206904A1 (en) | 2008-11-07 | 2014-07-24 | Evonik Oxeno Gmbh | Method for producing 6-chlorodibenzo[d,f] [1,3,2] dioxaphosphepin |
| US8729287B2 (en) | 2008-11-07 | 2014-05-20 | Evonik Oxeno Gmbh | Method for producing 6-chlorodibenzo[d,f] [1,3,2]-dioxaphosphepin |
| US8609878B2 (en) | 2008-11-07 | 2013-12-17 | Evonik Oxeno Gmbh | Method for producing 6-chlorodibenzo[D,F] [1 3,2]Dioxaphosphepin |
| US20150011139A1 (en) | 2009-01-16 | 2015-01-08 | Zeus Industrial Products, Inc. | Electrospinning of ptfe with high viscosity materials |
| US9000220B2 (en) | 2009-08-31 | 2015-04-07 | Evonik Degussa Gmbh | Organophosphorus compounds based on tetraphenol (TP)-substituted structures |
| US9127030B2 (en) | 2011-01-13 | 2015-09-08 | Evonik Degussa Gmbh | Method for the preparation of biphephos |
| US20130317246A1 (en) | 2011-01-13 | 2013-11-28 | Evonik Oxeno Gmbh | Method for the purification of biphephos |
| WO2012095253A1 (en) | 2011-01-13 | 2012-07-19 | Evonik Oxeno Gmbh | Method for producing biphephos |
| WO2012095255A1 (en) | 2011-01-13 | 2012-07-19 | Evonik Oxeno Gmbh | Method for the purification of biphephos |
| US20140309423A1 (en) | 2011-11-08 | 2014-10-16 | Evonik Degussa Gmbh | Novel organophosphorus compounds based on anthracenetriol |
| US20150011132A1 (en) | 2012-02-03 | 2015-01-08 | Jx Nippon Mining & Metals Corporation | Press-fit terminal and electronic component using the same |
| US20150266008A1 (en) | 2012-10-12 | 2015-09-24 | Evonik Degussa Gmbh | Mixture of different asymmetrical bisophosphites and use thereof as a catalyst mixture in hydroformylation |
| WO2014056735A1 (en) | 2012-10-12 | 2014-04-17 | Evonik Degussa Gmbh | Mixture of constitutional isomer bisphosphites |
| DE102013219508A1 (en) | 2012-10-12 | 2014-04-17 | Evonik Degussa Gmbh | Mixture useful as a catalyst for hydroformylating unsaturated compound or its mixture, comprises e.g. 6,6'-(3,3'-di-tert-butyl-5,5'-dimethoxybiphenyl-2,2'-diyl)bis(oxy)bis(2,4,8,10-tetramethyldibenzo(d,f)(1,3,2)dioxaphosphepine) |
| DE102013219506A1 (en) | 2012-10-12 | 2014-04-17 | Evonik Degussa Gmbh | New 4,8-di-tert-butyl-2,10-dimethoxy-6-(3,3',5,5'-tetramethyl-2'-(2,4,8,10-tetramethyldibenzo(d,f)(1,3,2)dioxaphosphepin-6-yloxy)biphenyl-2-yloxy)dibenzo(d,f)(1,3,2)dioxaphosphepine useful as catalyst to hydroformylate unsaturated compound |
| US20150273455A1 (en) | 2012-10-12 | 2015-10-01 | Evonik Degussa Gmbh | Mixtures of constitutionally isomeric bisphosphites |
| US20150290633A1 (en) | 2012-10-12 | 2015-10-15 | Evonik Degussa Gmbh | Asymmetrical bisphosphite |
| US9272973B2 (en) | 2012-10-12 | 2016-03-01 | Evonik Industries Ag | Stable long-term method for producing C5-aldehydes |
| US9206105B2 (en) | 2012-10-12 | 2015-12-08 | Evonik Degussa Gmbh | Mixture of bisphosphites and use thereof as a catalyst mixture in hydroformylation |
| US20160010225A1 (en) | 2013-03-07 | 2016-01-14 | Evonik Degussa Gmbh | Electrochemical coupling of two phenols which differ in their oxidation potential |
| US20160010226A1 (en) | 2013-03-07 | 2016-01-14 | Evonik Degussa Gmbh | Electrochemical coupling of anilines |
| US20160017504A1 (en) | 2013-03-07 | 2016-01-21 | Evonik Degussa Gmbh | Electrochemical process for coupling of phenol to aniline |
| US20160017505A1 (en) | 2013-03-07 | 2016-01-21 | Evonik Degussa Gmbh | Electrochemical coupling of a phenol to a naphthol |
| WO2014177355A1 (en) | 2013-05-03 | 2014-11-06 | Evonik Industries Ag | New quadridentate phosphorus ligands comprising hostanox o3 conductive structure |
| WO2015121007A1 (en) | 2014-02-12 | 2015-08-20 | Evonik Degussa Gmbh | Method for reducing the chlorine content of organobisphosphites |
| US9217003B2 (en) | 2014-02-12 | 2015-12-22 | Evonik Industries Ag | Preparation of 6,6′-((3,3′-di-tert-butyl-5,5′-dimethoxy-[1,1′-biphenyl]-2,2′-diyl)bis(oxy))bis(2,4,8,10-tetramethyldibenzo[d,f][1,3,2]dioxaphosphepine) |
| WO2015176929A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Degussa Gmbh | Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine |
| US9212195B1 (en) | 2014-05-20 | 2015-12-15 | Evonik Industries Ag | Monophosphite ligands having a carbonate group |
| US20150336861A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Degussa Gmbh | Preparation of high-quality oxo process alcohols from inconstant raw material sources |
| US9221850B2 (en) | 2014-05-20 | 2015-12-29 | Evonik Industries Ag | Monophosphite ligands having a tert-butyloxycarbonyl group |
| US9221851B2 (en) | 2014-05-20 | 2015-12-29 | Evonik Industries Ag | Mixture containing a monophosphite ligand and the use thereof for catalysis of a hydroformylation reaction |
| US20150336093A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Industries Ag | Process for catalytic preparation of aldehydes from olefins using monophosphite mixtures |
| WO2015176927A1 (en) | 2014-05-20 | 2015-11-26 | Evonik Degussa Gmbh | Method for reducing the chlorine content of organomonophosphites using two solutions |
| WO2015181018A1 (en) | 2014-05-26 | 2015-12-03 | Evonik Degussa Gmbh | Method for producing asymmetrical biphenols using selenium dioxide |
| US20150336995A1 (en) | 2014-05-26 | 2015-11-26 | Evonik Degussa Gmbh | Process for preparing 2,2'-biphenols using selenium dioxide and halogenated solvent |
| US20150336885A1 (en) | 2014-05-26 | 2015-11-26 | Evonik Degussa Gmbh | Process for preparing 2,2'-selenobiaryl ethers or 4,4'-selenobiaryl ethers using selenium dioxide |
| US20150336865A1 (en) | 2014-05-26 | 2015-11-26 | Evonik Degussa Gmbh | Process for preparing 2,2'-biphenols using selenium dioxide |
Non-Patent Citations (6)
| Title |
|---|
| Dyballa et al., U.S. Appl. No. 15/058,426, filed Mar. 2, 2016. |
| English language International Search Report mailed on May 4, 2015 in PCT/EP2015/050778 (3 pages). |
| Geilen et al., U.S. Appl. No. 15/040,058, filed Feb. 10, 2016. |
| German language International Search Report mailed on May 4, 2015 in PCT/EP2015/050778 (4 pages). |
| German language Search Report mailed on Sep. 3, 2014 in DE 10 2014 201 756.4 (8 pages). |
| German language Written Opinion mailed on May 4, 2015 in PCT/EP2015/050778 (6 pages). |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11769597B2 (en) | 2015-12-03 | 2023-09-26 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
| US11027266B2 (en) | 2016-11-08 | 2021-06-08 | Evonik Operations Gmbh | Phosphorous acid P,P′-[5,5′,6,6′-tetramethyl-3,3′-bis(l- methylethyl)[1,1′-biphenyl]-2,2′-diyl] P,P,P′,P'-tetrakis(2,4-dimethylphenyl) ester in hydroformylation |
| US10245578B2 (en) | 2016-11-09 | 2019-04-02 | Evonik Degussa Gmbh | Chromium- and nickel-free hydrogenation of hydroformylation mixtures |
| US10501392B2 (en) | 2017-12-01 | 2019-12-10 | Evonik Degussa Gmbh | Method for obtaining alcohols from aldehydes II |
| US10562833B2 (en) | 2017-12-01 | 2020-02-18 | Evonik Degussa Gmbh | Method for obtaining alcohols from aldehydes III |
| US10577297B2 (en) | 2017-12-01 | 2020-03-03 | Evonik Operations Gmbh | Method for obtaining alcohols from aldehydes |
| US10882027B2 (en) | 2018-03-14 | 2021-01-05 | Evonik Operations Gmbh | Process for producing an oligomerization catalyst |
| US10850261B2 (en) | 2018-03-14 | 2020-12-01 | Evonik Operations Gmbh | Oligomerization catalyst and process for the production thereof |
| US10882028B2 (en) | 2018-03-14 | 2021-01-05 | Evonik Operations Gmbh | Ni-containing catalyst for the oligomerization of olefins |
| US11253844B2 (en) | 2018-03-14 | 2022-02-22 | Evonik Operations Gmbh | Oligomerization catalyst and process for the production thereof |
| US11519020B2 (en) | 2018-05-25 | 2022-12-06 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
| US12116622B2 (en) | 2018-05-25 | 2024-10-15 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
| US10633302B2 (en) | 2018-07-25 | 2020-04-28 | Evonik Operations Gmbh | Process for oligomerization of butene with determination of the proportion of acidic catalysis |
| US10647650B2 (en) | 2018-10-05 | 2020-05-12 | Evonik Operations Gmbh | Process for hydroformylating short-chain olefins using a heterogenized catalyst system without ionic liquid |
| US10654784B2 (en) | 2018-10-05 | 2020-05-19 | Evonik Operations Gmbh | Process for hydroformylating short-chain olefins in the gas phase |
| US12337276B2 (en) | 2019-02-01 | 2025-06-24 | Evonik Operations Gmbh | Device and a membrane process for separating gas components from a gas stream having varying composition or flow rate |
| US11440863B2 (en) | 2019-06-12 | 2022-09-13 | Evonik Operations Gmbh | Process for preparing an alcohol from hydrocarbons |
| US11365171B2 (en) | 2019-06-12 | 2022-06-21 | Evonik Operations Gmbh | Process for preparing an ester by alkoxycarbonylation |
| US11008275B2 (en) | 2019-06-12 | 2021-05-18 | Evonik Operations Gmbh | Process for preparing carboxylic acids or salts thereof from hydrocarbons |
| US12064755B2 (en) | 2019-06-12 | 2024-08-20 | Evonik Oxeno Gmbh & Co. Kg | Process for separating one or more components from a mixture |
| US12246310B2 (en) | 2019-11-05 | 2025-03-11 | Dow Technology Investments Llc | Processes for recovery of rhodium from a hydroformylation process |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3099700A1 (en) | 2016-12-07 |
| TW201542576A (en) | 2015-11-16 |
| EP3099700B1 (en) | 2018-08-29 |
| CN105940006A (en) | 2016-09-14 |
| WO2015113840A1 (en) | 2015-08-06 |
| US20160326197A1 (en) | 2016-11-10 |
| DE102014201756A1 (en) | 2015-08-06 |
| CN105940006B (en) | 2018-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9676805B2 (en) | Purifying organophosphorus compounds contaminated with chlorine | |
| CN101684130B (en) | Preparation method of phosphite ester | |
| US9751904B2 (en) | Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine | |
| DE69105286T2 (en) | Carbonylation catalyst system. | |
| EP2395010B1 (en) | Method for the purification of triorganophosphites by treatment with a basic additive | |
| EP1697387B1 (en) | Method for producing trivalent organophosphorus compounds | |
| KR102602992B1 (en) | Economical production of 2-propylheptanol | |
| JP6042452B2 (en) | Method for purifying organic diphosphite compounds | |
| DE102009001225A1 (en) | Process for the enrichment of a homogeneous catalyst from a process stream | |
| CN104781225A (en) | Stable long-term method for producing C5-aldehydes | |
| US20150299079A1 (en) | Control of the viscosity of reaction solutions in hydroformylation methods | |
| DE102013217166A1 (en) | Process for the hydroformylation of unsaturated compounds by SILP catalysis | |
| Gavrilov et al. | Chiral ionic phosphites and diamidophosphites: a novel group of efficient ligands for asymmetric catalysis | |
| CN103917547A (en) | Novel organophosphorus compounds based on anthracenetriol | |
| EP2043780A1 (en) | Catalyst precursor for an rh complex catalyst | |
| CN106536533A (en) | Method for reducing the chlorine content of organobisphosphites | |
| DE10360772A1 (en) | Process for the preparation of organoacyl phosphites | |
| TWI605872B (en) | Catalyst preparation process | |
| DE60018295T2 (en) | HYDROFORMYLATION PROCEDURES USING PHOSPHITLIGANDES | |
| EP2231330A1 (en) | Phosphonite containing catalysts for hydroformylation processes | |
| EP3438111B1 (en) | Phosphinites with a tertiary butyl group bound directly to the phosphor | |
| US20170014816A1 (en) | Phosphoramidite derivatives in the hydroformylation of olefin-containing mixtures | |
| EP3388146B1 (en) | Ligands and method for hydroformylation using a 5-methyl-4,4-diphenyl-1,3,2-dioxaphospholane | |
| US20250382314A1 (en) | Bisphosphites with a naphthol outer unit | |
| EP3438112A1 (en) | Ligand having an o p o bridge between two anthracentriol building blocks |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| AS | Assignment |
Owner name: EVONIK DEGUSSA GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DYBALLA, KATRIN MARIE;FRANKE, ROBERT;FRIDAG, DIRK;AND OTHERS;SIGNING DATES FROM 20170125 TO 20170427;REEL/FRAME:042293/0981 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| AS | Assignment |
Owner name: EVONIK OPERATIONS GMBH, GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:EVONIK DEGUSSA GMBH;REEL/FRAME:051428/0710 Effective date: 20191104 |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
| AS | Assignment |
Owner name: EVONIK OXENO GMBH & CO. KG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EVONIK OPERATIONS GMBH;REEL/FRAME:065692/0785 Effective date: 20231012 Owner name: EVONIK OXENO GMBH & CO. KG, GERMANY Free format text: ASSIGNMENT OF ASSIGNOR'S INTEREST;ASSIGNOR:EVONIK OPERATIONS GMBH;REEL/FRAME:065692/0785 Effective date: 20231012 |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |








